We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ultrasound Imaging Technology Allows Doctors to Watch Spinal Cord Activity during Surgery

By HospiMedica International staff writers
Posted on 11 Mar 2024

Back pain treatments during surgery have historically been difficult to evaluate effectively, largely because patients under anesthesia cannot communicate their pain levels. More...

Furthermore, imaging the spinal cord – a crucial part of back pain treatment assessment – presents its own challenges. The spinal cord, referred to as an "unfriendly area" for traditional imaging, is subject to significant motion artifacts caused by heart pulsation and breathing, which introduce unwanted noise into the signal. These factors make the spinal cord a challenging target for standard neuroimaging techniques. Now, for the first time, an ultrasound imaging technology enables the generation of high-resolution images of the human spinal cord during surgery, marking a significant advancement that could provide relief for millions suffering from chronic back pain.

The technology, known as fUSI or functional ultrasound imaging, has been developed by scientists at UC Riverside (Riverside, CA, USA) and enables clinicians to observe the spinal cord and map its response to various treatments in real-time. Notably, the fUSI scanner is mobile and does not require the extensive infrastructure typically associated with classical neuroimaging methods like functional magnetic resonance imaging (fMRI). Additionally, fUSI has a reduced sensitivity to motion artifacts compared to other imaging techniques. It works by emitting sound waves into the targeted area, and the red blood cells in that region echo the sound back, producing a detailed image.

The application of fUSI was tested on six patients suffering from chronic low back pain, all of whom were scheduled for last-resort pain surgery, as no other treatments, including medication, had provided relief. In these procedures, clinicians stimulated the spinal cord with electrodes, hoping that the electrical stimulation would lessen the patients’ pain and enhance their quality of life. The results revealed that fUSI could detect changes in blood flow at unprecedentedly low speeds, less than one millimeter per second, marking a significant improvement over the two-centimeter-per-second detection capability of fMRI. This level of sensitivity suggests that the success rate of such surgeries, currently around 50%, could be significantly improved with the use of fUSI. Going forward, the researchers also plan to demonstrate fUSI's potential in optimizing treatments for individuals who have lost bladder control due to spinal cord injuries or aging.

“With less risk of damage than older methods, fUSI will enable more effective pain treatments that are optimized for individual patients,” said Vasileios Christopoulos, assistant professor of bioengineering at UC Riverside, who is pioneering the use of fUSI for spinal cord imaging. “It is a very exciting development.”

Related Links:
UC Riverside


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.